Investors will be eagerly watching for the performance of Vertex Pharmaceuticals in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on August 1, 2024. The company is expected to report EPS of $4.14, up 6.43% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $2.64 billion, indicating a 6.01% increase compared to the same quarter of the previous year. The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), po ...